Literature DB >> 19388138

P-type ATPases as drug targets: tools for medicine and science.

Laure Yatime1, Morten J Buch-Pedersen, Maria Musgaard, J Preben Morth, Anne-Marie Lund Winther, Bjørn P Pedersen, Claus Olesen, Jens Peter Andersen, Bente Vilsen, Birgit Schiøtt, Michael G Palmgren, Jesper V Møller, Poul Nissen, Natalya Fedosova.   

Abstract

P-type ATPases catalyze the selective active transport of ions like H+, Na+, K+, Ca2+, Zn2+, and Cu2+ across diverse biological membrane systems. Many members of the P-type ATPase protein family, such as the Na+,K+-, H+,K+-, Ca2+-, and H+-ATPases, are involved in the development of pathophysiological conditions or provide critical function to pathogens. Therefore, they seem to be promising targets for future drugs and novel antifungal agents and herbicides. Here, we review the current knowledge about P-type ATPase inhibitors and their present use as tools in science, medicine, and biotechnology. Recent structural information on a variety of P-type ATPase family members signifies that all P-type ATPases can be expected to share a similar basic structure and a similar basic machinery of ion transport. The ion transport pathway crossing the membrane lipid bilayer is constructed of two access channels leading from either side of the membrane to the ion binding sites at a central cavity. The selective opening and closure of the access channels allows vectorial access/release of ions from the binding sites. Recent structural information along with new homology modeling of diverse P-type ATPases in complex with known ligands demonstrate that the most proficient way for the development of efficient and selective drugs is to target their ion transport pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19388138     DOI: 10.1016/j.bbabio.2008.12.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  49 in total

Review 1.  Targeting Na/K-ATPase Signaling: A New Approach to Control Oxidative Stress.

Authors:  Jiang Liu; Megan N Lilly; Joseph I Shapiro
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

2.  Molecular characterization of mutant Arabidopsis plants with reduced plasma membrane proton pump activity.

Authors:  Miyoshi Haruta; Heather L Burch; Rachel B Nelson; Greg Barrett-Wilt; Kelli G Kline; Sheher B Mohsin; Jeffery C Young; Marisa S Otegui; Michael R Sussman
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

3.  Molecular simulations and free-energy calculations suggest conformation-dependent anion binding to a cytoplasmic site as a mechanism for Na+/K+-ATPase ion selectivity.

Authors:  Asghar M Razavi; Lucie Delemotte; Joshua R Berlin; Vincenzo Carnevale; Vincent A Voelz
Journal:  J Biol Chem       Date:  2017-06-06       Impact factor: 5.157

Review 4.  P2C-Type ATPases and Their Regulation.

Authors:  Rocío Retamales-Ortega; Carlos P Vio; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2015-01-29       Impact factor: 5.590

5.  Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.

Authors:  Matteo Marchesini; Andrea Gherli; Anna Montanaro; Laura Patrizi; Claudia Sorrentino; Luca Pagliaro; Chiara Rompietti; Samuel Kitara; Sabine Heit; Claus E Olesen; Jesper V Møller; Monia Savi; Leonardo Bocchi; Rocchina Vilella; Federica Rizzi; Marilena Baglione; Giorgia Rastelli; Caterina Loiacono; Roberta La Starza; Cristina Mecucci; Kimberly Stegmaier; Franco Aversa; Donatella Stilli; Anne-Marie Lund Winther; Paolo Sportoletti; Maike Bublitz; William Dalby-Brown; Giovanni Roti
Journal:  Cell Chem Biol       Date:  2020-05-07       Impact factor: 8.116

6.  Dynamics of the Plasma Membrane Proton Pump.

Authors:  Federico Guerra; Ana-Nicoleta Bondar
Journal:  J Membr Biol       Date:  2014-10-02       Impact factor: 1.843

7.  Dynamics-Driven Allostery Underlies Ca2+-Mediated Release of SERCA Inhibition by Phospholamban.

Authors:  Olga N Raguimova; Rodrigo Aguayo-Ortiz; Seth L Robia; L Michel Espinoza-Fonseca
Journal:  Biophys J       Date:  2020-09-24       Impact factor: 4.033

8.  In silico structural characterization of protein targets for drug development against Trypanosoma cruzi.

Authors:  Carlyle Ribeiro Lima; Nicolas Carels; Ana Carolina Ramos Guimaraes; Pierre Tufféry; Philippe Derreumaux
Journal:  J Mol Model       Date:  2016-09-24       Impact factor: 1.810

9.  The DosR dormancy regulator of Mycobacterium tuberculosis stimulates the Na(+)/K (+) and Ca (2+) ATPase activities in plasma membrane vesicles of mycobacteria.

Authors:  Paola A Pulido; Lorena Novoa-Aponte; Nicolás Villamil; Carlos Y Soto
Journal:  Curr Microbiol       Date:  2014-06-18       Impact factor: 2.188

10.  Antifungal Mechanism of Action of Lactoferrin: Identification of H+-ATPase (P3A-Type) as a New Apoptotic-Cell Membrane Receptor.

Authors:  María T Andrés; Maikel Acosta-Zaldívar; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.